Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tofogliflozin vs Glimepiride in T2DM and NAFLD
NCT02649465Phase 4Completed
- Sponsor
- Kanazawa University
- Start
- Nov 2015
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tofogliflozin in non-alcoholic fatty liver disease (NAFLD), sponsored by Kanazawa University. Started Nov 2015; status: completed.
02
Drugs
tofogliflozin
03
Conditions
non-alcoholic fatty liver disease (NAFLD)
Beyond the preview
Go deeper on NCT02649465.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02649465.